Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
bpc 157 and retatrutide BPC-157 5mg GLP-1 Pipeline Update: August sprinkles Dose:0.50 mg
GLP-1 Pipeline Update: August 2025 - Prime Therapeutics - Portal
In parallel, multi-target agents offer synergistic metabolic and weight-lowering effects, as exemplified by retatrutide (GLP-1R/GIPR/GCGR agonist) and NA931 (GLP-1R/GIPR/GCGR/IGF1 agonist), both of which demonstrate potent efficacy with acceptable tolerability (Rosenstock et al., 2023
sprinkles
Dose:0.50 mg
The dataset was normalized and log2-transformed before further processing
